ComparePhreesiavsSully.ai

Phreesia is a patient intake and engagement platform that automates registration, scheduling support, and payments for practices. The product is positioned around patient access, scheduling efficiency, and outbound communication, and workflow integration with the EHR drives the measurable outcomes that buyers can expect over time. Buyers should confirm EHR write-back depth, channel coverage, message governance, and patient population fit before rolling the platform out across active access programs and service lines.

The clearest fit for Phreesia is practices and health systems, and the product leans into established patient intake automation at scale. One real limitation: intake focus rather than ambient clinical AI. Pricing is sales-led and scoped per buyer rather than posted publicly. Confirm validation depth, support coverage, and the rollout plan before signing.

Sully.ai is an AI medical scribe and clinical assistant that drafts notes from patient visits and supports related documentation tasks. The product is positioned around ambient capture, structured note drafting, and EHR workflow rather than autonomous documentation, and clinician review of every drafted note remains essential before sign-off. Buyers should confirm specialty fit, EHR integration depth, documentation accuracy, and clinician training plan before scaling rollout across teams.

Buyers usually compare Sully.ai for an all-in-one AI clinician assistant approach, with clinics and physician practices as the core audience. The trade-off to keep in mind: specialty depth varies across practice types. Pricing is sales-led and scoped per buyer rather than posted publicly. A focused pilot, scoped to one workflow, is usually the cleanest way to test fit.